The authors reply

समान संसाधन

• Sacubitril/valsartan in peritoneal dialysis—lessons from a pharmacokinetic study
  द्वारा: Judge, PK, और अन्य
  प्रकाशित: (2023)
• Allocated but not treated: the silent 16% – Authors' reply
  द्वारा: Horby, P, और अन्य
  प्रकाशित: (2022)
• Authors' reply
  द्वारा: Herrington, W, और अन्य
  प्रकाशित: (2018)
• Impact of primary kidney disease on the effects of empagliflozin in patients with CKD
  द्वारा: Judge, PK, और अन्य
  प्रकाशित: (2023)
• The prevention and management of chronic kidney disease among patients with metabolic syndrome
  द्वारा: Zhu, D, और अन्य
  प्रकाशित: (2025)